Evolva starts commercial resveratrol production
30-May-2014
- Switzerland
Evolva has appointed a contract manufacturer in North America to produce commercial batches of resveratrol and expects to receive first deliveries in Q3 2014. Work on further reducing production costs will continue post-launch. Discussions with a global network of distributors are ongoing to accelerate sales post-launch.
Most read news
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.